Federal Grant System Under Siege: The OMB’s Proposed Overhaul and the Battle for Scientific Integrity on November 21, 2026 Posted by
Protecting the Next Generation: Istanbul Summit Confronts the Escalating Youth Nicotine Crisis on November 21, 2026 Posted by
Biopharma Industry Weekly Briefing: Strategic Shifts, Clinical Setbacks, and AI Partnerships on November 21, 2026 Posted by
Beyond the Wake: Uncovering the Hidden Cardiovascular Risks of Narcolepsy and Idiopathic Hypersomnia on November 21, 2026 Posted by
Clash of Titans: Thailand and Vietnam Set for High-Stakes ASEAN Cup 2026 Final Showdown on November 21, 2026 Posted by
Federal Grant System Under Siege: The OMB’s Proposed Overhaul and the Battle for Scientific Integrity on November 21, 2026 Posted by
Protecting the Next Generation: Istanbul Summit Confronts the Escalating Youth Nicotine Crisis on November 21, 2026 Posted by
Biopharma Industry Weekly Briefing: Strategic Shifts, Clinical Setbacks, and AI Partnerships on November 21, 2026 Posted by
Posted in Medical Innovations New Hope for Advanced Lung Cancer: FDA Approves Zidesamtinib for Pre-Treated ROS1-Positive NSCLC on July 23, 2026
Posted in Medical Innovations A New Frontier in Cardiology: FDA Approves Lipfendra, the First Oral PCSK9 Inhibitor on July 17, 2026
Posted in Sleep Health A New Frontier in Sleep Medicine: Health Canada Approves Zepbound for Obstructive Sleep Apnea on July 12, 2026
Posted in Sleep Health A New Era in Sleep Medicine: Health Canada Approves Zepbound for Obstructive Sleep Apnea on July 2, 2026
Posted in Digital Health Tools A New Era in Thyroid Eye Disease: FDA Approves Viridian’s Lumvoa, Challenging the Amgen Monopoly on June 29, 2026
Posted in Sleep Health A New Era in Sleep Medicine: Health Canada Approves Zepbound for Obstructive Sleep Apnea on June 25, 2026
Posted in Caregiver Support A New Era in Photoprotection: FDA Approves First New Sunscreen Ingredient in Over 25 Years on June 23, 2026
Posted in Medical Innovations A New Standard in Flu Care: FDA Approves First Generic Baloxavir Marboxil on June 22, 2026
Posted in Respiratory Health Expanding the Lifeline: FDA Approves Rextovy for Over-the-Counter Opioid Overdose Reversal on June 18, 2026
Posted in Respiratory Health FDA Approves First Generic Baloxavir Marboxil: A New Era for Influenza Management on June 18, 2026